Zobrazeno 1 - 10
of 202
pro vyhledávání: '"Afschin Gandjour"'
Autor:
Afschin Gandjour
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Introduction With an upward trend in adoption by industrialized nations, pay-for-performance (P4P) mechanisms are increasingly recognized for fostering quality improvement in healthcare. P4P programs conventionally reward providers with supp
Externí odkaz:
https://doaj.org/article/c048551f6f2e42748a8a4ea1b1dfed46
Autor:
Afschin Gandjour
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Introduction Protocol-driven trial activities contribute to the utility gain demonstrated in the phase III clinical trial of a new drug. If this utility gain cannot be distinguished from the effects of the new drug itself, protocol-driven tr
Externí odkaz:
https://doaj.org/article/d49684efe6e5458388ce9a31fdd1d8df
Autor:
Afschin Gandjour
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Objectives Value-based pricing (VBP) determines product prices based on their perceived benefits. In healthcare, VBP prices medical technologies considering health outcomes and other relevant factors. This study applies VBP using economic ev
Externí odkaz:
https://doaj.org/article/a5f0a5f445ec4322b87b19c68e8c7fa6
Autor:
Afschin Gandjour
Publikováno v:
PLoS ONE, Vol 19, Iss 7, p e0307086 (2024)
BackgroundMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) imposes a substantial societal and economic burden. The aim of this study is to ascertain the optimal level of public research and development (R&D) investment in Germany for a pro
Externí odkaz:
https://doaj.org/article/58c39e0a99a447a0ab81816a1fe640a4
Autor:
Afschin Gandjour
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Patients with acute COVID-19 can develop persistent symptoms (long/post COVID-19 syndrome). This study aimed to project the economic, health care, and pension costs due to long/post-COVID-19 syndrome with new onset in Germany in 2
Externí odkaz:
https://doaj.org/article/a035d382956b44d6b143b32953c87995
Autor:
Afschin Gandjour
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background and aim The first SARS-CoV-2 pandemic wave in Germany involved a tradeoff between saving the lives of COVID-19 patients by providing sufficient intensive care unit (ICU) capacity and foregoing the health benefits of elective proce
Externí odkaz:
https://doaj.org/article/c850ea7469ae4c92809c00bba31ce609
Autor:
Afschin Gandjour
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Aim The European Union (EU) has received criticism for being slow to secure coronavirus disease (COVID-19) vaccine contracts in 2020 before the approval of the first COVID-19 vaccine. This study aimed to retrospectively analyze the EU’s CO
Externí odkaz:
https://doaj.org/article/7551088553004f2f8b30601caf617b47
Autor:
Afschin Gandjour
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background The aim of this study is to quantify the health benefits, risks, and cost-effectiveness of COVID-19 self-tests from a consumer’s perspective in Germany. Methods The analysis is based on a modelling approach using secondary data.
Externí odkaz:
https://doaj.org/article/d5e80d796d5a4792a9febb544159b9b7
Autor:
Afschin Gandjour
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0285083 (2023)
Background/aimDuring the coronavirus disease (COVID-19) pandemic, Germany and various other countries experienced a shortage of polymerase chain reaction (PCR) laboratory tests due to the highly transmissible SARS-CoV-2 Omicron variant that drove an
Externí odkaz:
https://doaj.org/article/c4dc46fba6fe4c9db9240c3f96ee33b8
Autor:
Afschin Gandjour
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Health care systems around the world struggle with high prices for new cancer drugs. The purpose of this study was to conduct a gedankenexperiment and calculate how much health expenditures would change if a cure for cancer throug
Externí odkaz:
https://doaj.org/article/f69629f3e06145deb6bd681985e1025a